Viewing Study NCT01228760


Ignite Creation Date: 2025-12-25 @ 2:08 AM
Ignite Modification Date: 2026-06-26 @ 5:56 AM
Study NCT ID: NCT01228760
Status: COMPLETED
Last Update Posted: 2013-06-07
First Post: 2010-10-21
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Study to Determine the Maximum Tolerated Dose of ASG-5ME in Subjects With Castration-Resistant Prostate Cancer
Sponsor: Astellas Pharma Inc
Organization:

Organization Data

Organization:
Class: INDUSTRY
Study ID: ASG-5ME-10-1
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators

Collaborators

Name Class View
None INDUSTRY View